Response to

‘Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’’ by Ruscitti et al

¹ Medicine, Rheumatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
² Rheumatology, University of Nebraska Medical Center, Omaha, Nebraska, USA
³ Rheumatology, VA Nebraska-Western Iowa Health Care System, Omaha, Nebraska, USA
⁴ Department of Medicine, University of Nebraska System, Lincoln, Nebraska, USA

Dr Joshua F Baker, Medicine, Rheumatology, University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected]

Received February 09, 2021

Accepted February 11, 2021

Annals of the Rheumatic Diseases 82(5):p e120, May 2023. | DOI: 10.1136/annrheumdis-2021-220114